Project Grant HT9425261E032
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $840K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Phoenix, AZ 85013, USA
Similar Awards
- Federal Project Grant Award Summary Arizona State University received a $962,713 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2025, with a completion date of June 14, 2028. The award supports research focused on developing robust subtype markers for amyotrophic lateral sclerosis (ALS) patient stratification. This initiative aligns with the DHA's mission to advance biomedical research that transforms...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Denver Research Institute a $2.31M Project Grant under the Military Medical Research and Development program (CFDA 12.420) beginning July 1, 2025, and concluding June 30, 2029. The award funds the Development and Evaluation of a Care Pathway for Evaluation and Management of the Respiratory Syndromes of Amyotrophic Lateral Sclerosis (CAPRESA), a clinical research initiative to be conducted at the Institute's Denver, Colorado...
- Federal Project Grant Award Summary Sanford Burnham Prebys Medical Discovery Institute received a $1,078,882 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2027. The award supports research applying chemical engineering approaches to amyotrophic lateral sclerosis (ALS) treatment, with a focus on advancing understanding of the multimodal therapeutic actions of donor and host neural...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Methodist Hospital Research Institute a $998,039 project grant under the Military Medical Research and Development program (CFDA 12.420) to conduct a large-scale multiomic study identifying systemic and central immune-related biomarkers in amyotrophic lateral sclerosis (ALS). The three-year research initiative, commencing May 1, 2026 and concluding April 30, 2029, will be performed at the institute's Houston, Texas...
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $999,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on June 1, 2026. The award funds research titled "Schwann Cell-Derived Extracellular Vesicle Platform for ALS Biomarker Discovery in Biofluids" with a completion date of May 31, 2029. This project delivers biomarker discovery research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $939,325 to the Weizmann Institute of Science on November 1, 2025, under the Military Medical Research and Development program (CFDA 12.420) to support the GLOBALS (Global Omic Biomarker Research for ALS) initiative. This three-year project, extending through October 31, 2028, funds advanced biomedical research focused on discovering and developing omic biomarkers for amyotrophic lateral sclerosis (ALS). The research...
- Federal Grant Award Summary New York University School of Medicine received a $1.0 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the three-year period from June 1, 2026, through May 31, 2029. The award funds research into diffusion magnetic resonance imaging (MRI) biomarkers of axonal degeneration in amyotrophic lateral sclerosis (ALS). This research initiative will advance understanding of neurodegeneration...
- Federal Project Grant Award Summary The Washington University's Office of Sponsored Research Services received a $840,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2026, through May 31, 2028. The award supports research investigating hyperphosphorylation of tau serine 262 as a novel biomarker and therapy target in amyotrophic lateral sclerosis (ALS). This research initiative aligns with...
- Federal Grant Award Summary Emory University received a $840,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period April 1, 2026 through March 31, 2028. The award supports research to repurpose approved drugs as first-in-class disruptors of the P38/MK2 (p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2) complex to suppress neuroinflammation in amyotrophic...
- Federal Project Grant Award Summary Award Details: Modulo Bio, Inc. received a $1.74M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with an award date of May 1, 2026, and a performance period through April 30, 2028. This administrative modification corrected the payment office DODAAC code for processing purposes without altering the award amount or other terms and conditions. Products and Services: Under this award,...